Anke Sieg

Anke Sieg currently serves as Head of JCA; Payer, Policy and RWE Organisation at UCB, with a focus on market access and pricing strategy for assets in clinical development within immunology and rare diseases. Prior roles at UCB included Global Payer Value Strategy - Asset Lead and Global Commercial Strategy Director for early compounds across nephrology and neurology. Anke also held the position of Treasurer and Executive Director at Professional Women International Brussels, advocating for diversity and gender equity. Previous experience includes significant roles at Dow Corning, Baxter R&D Europe, and Procter & Gamble, with a strong focus on innovation in medical devices, pharmaceuticals, and dermatology. Anke holds a PhD in Pharmaceutical Sciences from the University of Geneva and several advanced degrees, including an MBA from Solvay Brussels School and a postgraduate degree from The London School of Economics.